151 related articles for article (PubMed ID: 27121973)
1. Roles of Copper in Hepatocarcinogenesis via the Activation of Hypoxia-Inducible Factor-1α.
Himoto T; Fujita K; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Kubota S; Haba R; Suzuki Y; Masaki T
Biol Trace Elem Res; 2016 Nov; 174(1):58-64. PubMed ID: 27121973
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinoma.
Yao DF; Jiang H; Yao M; Li YM; Gu WJ; Shen YC; Qiu LW; Wu W; Wu XH; Sai WL
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):407-13. PubMed ID: 19666411
[TBL] [Abstract][Full Text] [Related]
4. [Hypoxia-inducible factor-1α mediates and regulates angiogenesis-related factors expression in hepatocellular carcinoma].
Sun JY; Chen XY; Wang L; Ye WX; Shen SJ; Yang JL; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):942-948. PubMed ID: 33256280
[No Abstract] [Full Text] [Related]
5. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis.
Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K
Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871
[TBL] [Abstract][Full Text] [Related]
7. Defective Beclin-1 and elevated hypoxia-inducible factor (HIF)-1α expression are closely linked to tumorigenesis, differentiation, and progression of hepatocellular carcinoma.
Osman NA; Abd El-Rehim DM; Kamal IM
Tumour Biol; 2015 Jun; 36(6):4293-9. PubMed ID: 25596085
[TBL] [Abstract][Full Text] [Related]
8. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases.
Lin CC; Huang JF; Tsai LY; Huang YL
Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
10. [Expression of HIF-1alpha in serum of primary hepatocellular carcinoma and effects on tumor invasion and metastasis].
Zhang DH; Zhu WG; Yue S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 May; 27(5):551-2, 554. PubMed ID: 21796840
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of hepatitis B virus x protein and hypoxia-inducible factor-1alpha in hepatocellular carcinoma and their possible relationships].
Liu KG; Xie HH; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2007 Feb; 15(2):122-6. PubMed ID: 17362638
[TBL] [Abstract][Full Text] [Related]
12. Activity and expression pattern of NF-κB /P65 in peripheral blood from hepatocellular carcinoma patients - link to hypoxia inducible factor -1α.
Gaballah HH; Zakaria SS; Ismail SA
Asian Pac J Cancer Prev; 2014; 15(16):6911-7. PubMed ID: 25169545
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
Liu LP; Ho RL; Chen GG; Lai PB
Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
[TBL] [Abstract][Full Text] [Related]
14. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
[TBL] [Abstract][Full Text] [Related]
15. Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma.
Nagasue N; Kolno H; Chang YC; Nakamura T
Oncology; 1989; 46(5):293-6. PubMed ID: 2550861
[TBL] [Abstract][Full Text] [Related]
16. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
17. MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α.
Xu H; Zhao L; Fang Q; Sun J; Zhang S; Zhan C; Liu S; Zhang Y
PLoS One; 2014; 9(12):e115565. PubMed ID: 25531114
[TBL] [Abstract][Full Text] [Related]
18. Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma.
Tamai Y; Iwasa M; Eguchi A; Shigefuku R; Sugimoto K; Hasegawa H; Takei Y
PLoS One; 2020; 15(8):e0237370. PubMed ID: 32857769
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction represses HIF-1α protein synthesis through AMPK activation in human hepatoma HepG2 cells.
Hsu CC; Wang CH; Wu LC; Hsia CY; Chi CW; Yin PH; Chang CJ; Sung MT; Wei YH; Lu SH; Lee HC
Biochim Biophys Acta; 2013 Oct; 1830(10):4743-51. PubMed ID: 23791554
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of recurrence for serum hypoxia inducible factor-1α C-reaction protein in hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
Jing Q; Jianyong L; Jiming Y; Shuren L; Rui W; Wei L
Indian J Cancer; 2015 Dec; 52 Suppl 2():e105-6. PubMed ID: 26728665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
